How much does one tube of Teritolumab cost? Will the price fluctuate?

Teritusumab (teclistamab) is a monoclonal antibody drug used to treat multiple myeloma. It has been marketed in China but has not yet been included in medical insurance. Therefore, when patients purchase this drug in China, they need to consult the local hospital pharmacy for specific prices, as drug prices may vary depending on region, sales channel, and supply. Nonetheless, since it is not covered by medical insurance, patients are required to bear the cost of the medication themselves, which may create a financial burden for some patients.

In foreign markets, the original research version of teritusumab is more expensive. For example, a box of original drug with a specification of 153mg/1.7ml is priced at more than 50,000 yuan. This price usually includes factors such as production, transportation and taxes of the drug, so the selling price may vary in different regions. When patients choose to purchase from abroad, in addition to considering the price of the drug, they also need to pay attention to additional costs such as international logistics and customs duties.

Drug prices are likely to fluctuate in the future. Price fluctuations are usually affected by a variety of factors, such as changes in drug production costs, exchange rate fluctuations, market supply and demand, and policy changes. If drugs are covered by medical insurance in the future, prices may be regulated, reducing the financial burden on patients. In addition, if competition from generic or imported drugs emerges, prices may also be affected. When purchasing, patients can choose the best time to purchase based on market conditions.

In general, the price of teritusumab is subject to certain fluctuations. When considering medication, patients should discuss treatment options with their doctors and make reasonable choices based on their own economic situation and drug price fluctuations. In the absence of medical insurance reimbursement, patients may need to obtain drug information through other channels and ensure the legality and safety of drug sources.

Reference materials:https://www.tecvayli.com/